• LAST PRICE
    0.0110
  • TODAY'S CHANGE (%)
    Trending Up0.0010 (10.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0095 / 0.0100
  • Day Range
    Low 0.0095
    High 0.0110
  • 52 Week Range
    Low 0.0045
    High 0.1100
  • Volume
    403,300
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.01
TimeVolumeMOBO
10:50 ET533000.0095
12:41 ET700000.00995
12:45 ET800000.01
03:50 ET500000.01
03:54 ET1500000.011
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMOBO
Avail Scientific Inc
4.1M
-0.7x
---
United StatesGBLX
GB Sciences Inc
4.1M
-0.7x
---
United StatesRNAZ
Transcode Therapeutics Inc
4.2M
-3.4x
---
United StatesXSNX
NovAccess Global Inc
4.2M
-1.4x
---
United StatesTMBR
Timber Pharmaceuticals Inc
4.1M
-0.1x
---
United StatesRASP
Rasna Therapeutics Inc
4.4M
-0.4x
---
As of 2023-05-27

Company Information

Avail Scientific Inc., formerly Mobile Lads Corp., is a clinical-stage biopharmaceutical company. The Company is engaged in developing and testing nano-technology in conjunction with its psychedelic therapeutics. It is focused on facilitating a medical and social re-evaluation of the pharmacological therapies for addiction using organic psilocybin and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). These substances can be used as both treatment for addiction and as preventative therapy addressing health challenges underlying substance abuse. Its program includes multi-tiered research programs and implementation of psychedelic therapy in Canada. Its psychedelic-based projects include development of psychedelic analogs for medical use, novel methods of medication absorption, and derived research. It has developed a scientific methodology that utilizes functional magnetic resonance imaging (fMRI) technology, artificial intelligence, and a licensed research facility.

Contact Information

Headquarters
326 ADELAIDE STREET WEST, 4TH FLOORTORONTO, ON, Canada M5V 1R3
Phone
416-953-3133
Fax
608-827-5501

Executives

President, Chief Executive Officer, Principal Executive Officer, Director
Michael Paul
Chief Financial Officer, Principal Accounting Officer, Treasurer, Secretary, Director
Alpha Pang
Director and Director of Business Development
Muhammad Afzal Khan
Chief Revenue Officer
Gerard Maynard

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.1M
Revenue (TTM)
$4.5K
Shares Outstanding
369.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.97
EPS
$-0.02
Book Value
$0.00
P/E Ratio
-0.7x
Price/Sales (TTM)
908.0
Price/Cash Flow (TTM)
---
Operating Margin
-96,148.77%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.